Medscape21d
Quality of Life and Chemotherapy-induced Neutropenia
Among the common adverse events with cancer chemotherapy are neutropenia, anemia, nausea and vomiting, mucositis, alopecia, pain, and fatigue.
Cure Today21h
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Nature1y
New European guidelines for the use of G-CSF for chemotherapy-induced neutropenia
Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...
Medscape10d
Three Cancer Medicines Green-Lighted in Europe
The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...
Cure Today1d
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.